XTR-010

N/A

Report date: 2025/11/20 13:28:14

NME

Base Information

Drug NameXTR-010

Drug Alias NameXTR-010XTR010

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Lutetium > 177Lu +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesBeijing Xiantong International Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A